Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Aziyo Biologics Inc is a medical devices business based in the US. Aziyo Biologics Inc shares (AZYO) are listed on the NASDAQ and all prices are listed in US Dollars. Aziyo Biologics Inc employs 157 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $7.23 |
|---|---|
| 52-week range | $4.10 - $11.10 |
| 50-day moving average | $6.42 |
| 200-day moving average | $6.21 |
| Wall St. target price | $10.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.47 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $7.23 from 2022-06-24
| 1 week (2022-06-17) | 14.58% |
|---|---|
| 1 month (2022-05-26) | 22.96% |
| 3 months (2022-03-25) | 33.15% |
| 6 months (2021-12-23) | 8.40% |
| 1 year (2021-06-25) | -32.87% |
|---|---|
| 2 years (2020-06-22) | N/A |
| 3 years (2019-06-22) | N/A |
| 5 years (2017-06-22) | N/A |
| Revenue TTM | $46 million |
|---|---|
| Gross profit TTM | $19 million |
| Return on assets TTM | -24.47% |
| Return on equity TTM | -242.7% |
| Profit margin | -60.68% |
| Book value | $0.48 |
| Market capitalisation | $98.5 million |
TTM: trailing 12 months
We're not expecting Aziyo Biologics Inc to pay a dividend over the next 12 months.
Aziyo Biologics, Inc. , a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
